Financial Metrics

GILD GILEAD SCIENCES, INC.

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	2.53	—	USD/shares	10-Q	2017-05-10
Quarterly	2016-06-30	2.58	+2.0%	USD/shares	10-Q	2017-08-07
Quarterly	2016-09-30	2.49	-3.5%	USD/shares	10-Q	2017-11-07
Quarterly	2017-03-31	2.05	-17.7%	USD/shares	10-Q	2018-05-09
Quarterly	2017-06-30	2.33	+13.7%	USD/shares	10-Q	2018-08-06
Quarterly	2017-09-30	2.06	-11.6%	USD/shares	10-Q	2018-11-06
Quarterly	2018-03-31	1.17	-43.2%	USD/shares	10-Q	2019-05-08
Quarterly	2018-06-30	1.39	+18.8%	USD/shares	10-Q	2019-08-06
Quarterly	2018-09-30	1.6	+15.1%	USD/shares	10-Q	2019-11-05
Quarterly	2019-03-31	1.54	-3.8%	USD/shares	10-Q	2020-05-06
Quarterly	2019-06-30	1.47	-4.5%	USD/shares	10-Q	2020-08-06
Quarterly	2019-09-30	-0.92	-162.6%	USD/shares	10-Q	2020-11-04
Quarterly	2020-03-31	1.22	+232.6%	USD/shares	10-Q	2021-05-06
Quarterly	2020-06-30	-2.66	-318.0%	USD/shares	10-Q	2021-08-05
Quarterly	2020-09-30	0.29	+110.9%	USD/shares	10-Q	2021-11-03
Quarterly	2021-03-31	1.37	+372.4%	USD/shares	10-Q	2022-05-04
Quarterly	2021-06-30	1.21	-11.7%	USD/shares	10-Q	2022-08-08
Quarterly	2021-09-30	2.05	+69.4%	USD/shares	10-Q	2022-11-02
Quarterly	2022-03-31	0.02	-99.0%	USD/shares	10-Q	2023-05-03
Quarterly	2022-06-30	0.91	+4450.0%	USD/shares	10-Q	2023-08-04
Quarterly	2022-09-30	1.42	+56.0%	USD/shares	10-Q	2023-11-07
Quarterly	2023-03-31	0.8	-43.7%	USD/shares	10-Q	2024-05-08
Quarterly	2023-06-30	0.83	+3.7%	USD/shares	10-Q	2024-08-08
Quarterly	2023-09-30	1.73	+108.4%	USD/shares	10-Q	2024-11-12
Quarterly	2024-03-31	-3.34	-293.1%	USD/shares	10-Q	2025-05-07
Quarterly	2024-06-30	1.29	+138.6%	USD/shares	10-Q	2025-08-07
Quarterly	2024-09-30	1.0	-22.5%	USD/shares	10-Q	2025-11-07
Quarterly	2025-03-31	1.04	+4.0%	USD/shares	10-Q	2025-05-07
Quarterly	2025-06-30	1.56	+50.0%	USD/shares	10-Q	2025-08-07
Quarterly	2025-09-30	2.43	+55.8%	USD/shares	10-Q	2025-11-07
Annual	2016-12-31	9.94	—	USD/shares	10-K	2019-02-26
Annual	2017-12-31	3.51	-64.7%	USD/shares	10-K	2020-02-25
Annual	2018-12-31	4.17	+18.8%	USD/shares	10-K	2021-02-25
Annual	2019-12-31	4.22	+1.2%	USD/shares	10-K	2022-02-23
Annual	2020-12-31	0.1	-97.6%	USD/shares	10-K	2023-02-22
Annual	2021-12-31	4.93	+4830.0%	USD/shares	10-K	2024-02-23
Annual	2022-12-31	3.64	-26.2%	USD/shares	10-K	2025-02-28
Annual	2023-12-31	4.5	+23.6%	USD/shares	10-K	2026-02-24
Annual	2024-12-31	0.38	-91.6%	USD/shares	10-K	2026-02-24
Annual	2025-12-31	6.78	+1684.2%	USD/shares	10-K	2026-02-24

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	21077000000.0	—	USD	10-Q	2016-05-06
Quarterly	2016-06-30	21427000000.0	+1.7%	USD	10-Q	2016-08-05
Quarterly	2016-09-30	26371000000.0	+23.1%	USD	10-Q	2016-11-07
Quarterly	2016-12-31	26346000000.0	-0.1%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	26321000000.0	-0.1%	USD	10-Q	2017-05-10
Quarterly	2017-06-30	26296000000.0	-0.1%	USD	10-Q	2017-08-07
Quarterly	2017-09-30	27515000000.0	+4.6%	USD	10-Q	2017-11-07
Quarterly	2017-12-31	33542000000.0	+21.9%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	26557000000.0	-20.8%	USD	10-Q	2018-05-09
Quarterly	2018-06-30	29060000000.0	+9.4%	USD	10-Q	2018-08-06
Quarterly	2018-09-30	27316000000.0	-6.0%	USD	10-Q	2018-11-06
Quarterly	2018-12-31	24574000000.0	-10.0%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	24080000000.0	-2.0%	USD	10-Q	2019-05-08
Quarterly	2019-06-30	24084000000.0	+0.0%	USD	10-Q	2019-08-06
Quarterly	2019-09-30	22090000000.0	-8.3%	USD	10-Q	2019-11-05
Quarterly	2019-12-31	22094000000.0	+0.0%	USD	10-Q	2020-11-04
Quarterly	2020-03-31	22098000000.0	+0.0%	USD	10-Q	2020-05-06
Quarterly	2020-06-30	21103000000.0	-4.5%	USD	10-Q	2020-08-06
Quarterly	2020-09-30	27792000000.0	+31.7%	USD	10-Q	2020-11-04
Quarterly	2020-12-31	31402000000.0	+13.0%	USD	10-Q	2021-11-03
Quarterly	2021-03-31	30166000000.0	-3.9%	USD	10-Q	2021-05-06
Quarterly	2021-06-30	30175000000.0	+0.0%	USD	10-Q	2021-08-05
Quarterly	2021-09-30	27686000000.0	-8.2%	USD	10-Q	2021-11-03
Quarterly	2021-12-31	26695000000.0	-3.6%	USD	10-Q	2022-11-02
Quarterly	2022-03-31	26208000000.0	-1.8%	USD	10-Q	2022-05-04
Quarterly	2022-06-30	26216000000.0	+0.0%	USD	10-Q	2022-08-08
Quarterly	2022-09-30	25223000000.0	-3.8%	USD	10-Q	2022-11-02
Quarterly	2022-12-31	25229000000.0	+0.0%	USD	10-Q	2023-11-07
Quarterly	2023-03-31	25238000000.0	+0.0%	USD	10-Q	2023-05-03
Quarterly	2023-06-30	25246000000.0	+0.0%	USD	10-Q	2023-08-04
Quarterly	2023-09-30	24982000000.0	-1.0%	USD	10-Q	2023-11-07
Quarterly	2023-12-31	24987000000.0	+0.0%	USD	10-Q	2024-11-12
Quarterly	2024-03-31	25193000000.0	+0.8%	USD	10-Q	2024-05-08
Quarterly	2024-06-30	23349000000.0	-7.3%	USD	10-Q	2024-08-08
Quarterly	2024-09-30	23249000000.0	-0.4%	USD	10-Q	2024-11-12
Quarterly	2024-12-31	26710000000.0	+14.9%	USD	10-Q	2025-11-07
Quarterly	2025-03-31	24952000000.0	-6.6%	USD	10-Q	2025-05-07
Quarterly	2025-06-30	24946000000.0	-0.0%	USD	10-Q	2025-08-07
Quarterly	2025-09-30	24941000000.0	-0.0%	USD	10-Q	2025-11-07
Annual	2016-12-31	26346000000.0	—	USD	10-K	2018-02-27
Annual	2017-12-31	30795000000.0	+16.9%	USD	10-K	2019-02-26
Annual	2018-12-31	24574000000.0	-20.2%	USD	10-K	2020-02-25
Annual	2019-12-31	22094000000.0	-10.1%	USD	10-K	2021-02-25
Annual	2020-12-31	31402000000.0	+42.1%	USD	10-K	2022-02-23
Annual	2021-12-31	26695000000.0	-15.0%	USD	10-K	2023-02-22
Annual	2022-12-31	25229000000.0	-5.5%	USD	10-K	2024-02-23
Annual	2023-12-31	24987000000.0	-1.0%	USD	10-K	2025-02-28
Annual	2024-12-31	26710000000.0	+6.9%	USD	10-K	2026-02-24
Annual	2025-12-31	24937000000.0	-6.6%	USD	10-K	2026-02-24

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	177000000.0	—	USD	10-Q	2017-05-10
Quarterly	2016-06-30	381000000.0	+115.3%	USD	10-Q	2017-08-07
Quarterly	2016-09-30	579000000.0	+52.0%	USD	10-Q	2017-11-07
Quarterly	2017-03-31	118000000.0	-79.6%	USD	10-Q	2018-05-09
Quarterly	2017-06-30	241000000.0	+104.2%	USD	10-Q	2018-08-06
Quarterly	2017-09-30	370000000.0	+53.5%	USD	10-Q	2018-11-06
Quarterly	2018-03-31	212000000.0	-42.7%	USD	10-Q	2019-05-08
Quarterly	2018-06-30	509000000.0	+140.1%	USD	10-Q	2019-08-06
Quarterly	2018-09-30	676000000.0	+32.8%	USD	10-Q	2019-11-05
Quarterly	2019-03-31	237000000.0	-64.9%	USD	10-Q	2020-05-06
Quarterly	2019-06-30	422000000.0	+78.1%	USD	10-Q	2020-08-06
Quarterly	2019-09-30	622000000.0	+47.4%	USD	10-Q	2020-11-04
Quarterly	2020-03-31	171000000.0	-72.5%	USD	10-Q	2021-05-06
Quarterly	2020-06-30	314000000.0	+83.6%	USD	10-Q	2021-08-05
Quarterly	2020-09-30	469000000.0	+49.4%	USD	10-Q	2021-11-03
Quarterly	2021-03-31	165000000.0	-64.8%	USD	10-Q	2022-05-04
Quarterly	2021-06-30	284000000.0	+72.1%	USD	10-Q	2022-08-08
Quarterly	2021-09-30	423000000.0	+48.9%	USD	10-Q	2022-11-02
Quarterly	2022-03-31	247000000.0	-41.6%	USD	10-Q	2023-05-03
Quarterly	2022-06-30	390000000.0	+57.9%	USD	10-Q	2023-08-04
Quarterly	2022-09-30	547000000.0	+40.3%	USD	10-Q	2023-11-07
Quarterly	2023-03-31	109000000.0	-80.1%	USD	10-Q	2024-05-08
Quarterly	2023-06-30	248000000.0	+127.5%	USD	10-Q	2024-08-08
Quarterly	2023-09-30	370000000.0	+49.2%	USD	10-Q	2024-11-12
Quarterly	2024-03-31	105000000.0	-71.6%	USD	10-Q	2025-05-07
Quarterly	2024-06-30	235000000.0	+123.8%	USD	10-Q	2025-08-07
Quarterly	2024-09-30	376000000.0	+60.0%	USD	10-Q	2025-11-07
Quarterly	2025-03-31	104000000.0	-72.3%	USD	10-Q	2025-05-07
Quarterly	2025-06-30	211000000.0	+102.9%	USD	10-Q	2025-08-07
Quarterly	2025-09-30	358000000.0	+69.7%	USD	10-Q	2025-11-07
Annual	2018-12-31	924000000.0	—	USD	10-K	2021-02-25
Annual	2019-12-31	825000000.0	-10.7%	USD	10-K	2022-02-23
Annual	2020-12-31	650000000.0	-21.2%	USD	10-K	2023-02-22
Annual	2021-12-31	579000000.0	-10.9%	USD	10-K	2024-02-23
Annual	2022-12-31	728000000.0	+25.7%	USD	10-K	2025-02-28
Annual	2023-12-31	585000000.0	-19.6%	USD	10-K	2026-02-24
Annual	2024-12-31	523000000.0	-10.6%	USD	10-K	2026-02-24
Annual	2025-12-31	563000000.0	+7.6%	USD	10-K	2026-02-24

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	1412000000.0	—	shares	10-Q	2017-05-10
Quarterly	2016-06-30	1355000000.0	-4.0%	shares	10-Q	2017-08-07
Quarterly	2016-09-30	1339000000.0	-1.2%	shares	10-Q	2017-11-07
Quarterly	2017-03-31	1320000000.0	-1.4%	shares	10-Q	2018-05-09
Quarterly	2017-06-30	1317000000.0	-0.2%	shares	10-Q	2018-08-06
Quarterly	2017-09-30	1319000000.0	+0.2%	shares	10-Q	2018-11-06
Quarterly	2018-03-31	1320000000.0	+0.1%	shares	10-Q	2019-05-08
Quarterly	2018-06-30	1308000000.0	-0.9%	shares	10-Q	2019-08-06
Quarterly	2018-09-30	1307000000.0	-0.1%	shares	10-Q	2019-11-05
Quarterly	2019-03-31	1283000000.0	-1.8%	shares	10-Q	2020-05-06
Quarterly	2019-06-30	1277000000.0	-0.5%	shares	10-Q	2020-08-06
Quarterly	2019-09-30	1267000000.0	-0.8%	shares	10-Q	2020-11-04
Quarterly	2020-03-31	1270000000.0	+0.2%	shares	10-Q	2021-05-06
Quarterly	2020-06-30	1255000000.0	-1.2%	shares	10-Q	2021-08-05
Quarterly	2020-09-30	1261000000.0	+0.5%	shares	10-Q	2021-11-03
Quarterly	2021-03-31	1262000000.0	+0.1%	shares	10-Q	2022-05-04
Quarterly	2021-06-30	1260000000.0	-0.2%	shares	10-Q	2022-08-08
Quarterly	2021-09-30	1262000000.0	+0.2%	shares	10-Q	2022-11-02
Quarterly	2022-03-31	1262000000.0	+0.0%	shares	10-Q	2023-05-03
Quarterly	2022-06-30	1260000000.0	-0.2%	shares	10-Q	2023-08-04
Quarterly	2022-09-30	1261000000.0	+0.1%	shares	10-Q	2023-11-07
Quarterly	2023-03-31	1261000000.0	+0.0%	shares	10-Q	2024-05-08
Quarterly	2023-06-30	1258000000.0	-0.2%	shares	10-Q	2024-08-08
Quarterly	2023-09-30	1257000000.0	-0.1%	shares	10-Q	2024-11-12
Quarterly	2024-03-31	1247000000.0	-0.8%	shares	10-Q	2025-05-07
Quarterly	2024-06-30	1251000000.0	+0.3%	shares	10-Q	2025-08-07
Quarterly	2024-09-30	1254000000.0	+0.2%	shares	10-Q	2025-11-07
Quarterly	2025-03-31	1259000000.0	+0.4%	shares	10-Q	2025-05-07
Quarterly	2025-06-30	1255000000.0	-0.3%	shares	10-Q	2025-08-07
Quarterly	2025-09-30	1254000000.0	-0.1%	shares	10-Q	2025-11-07
Annual	2016-12-31	1358000000.0	—	shares	10-K	2019-02-26
Annual	2017-12-31	1319000000.0	-2.9%	shares	10-K	2020-02-25
Annual	2018-12-31	1308000000.0	-0.8%	shares	10-K	2021-02-25
Annual	2019-12-31	1277000000.0	-2.4%	shares	10-K	2022-02-23
Annual	2020-12-31	1263000000.0	-1.1%	shares	10-K	2023-02-22
Annual	2021-12-31	1262000000.0	-0.1%	shares	10-K	2024-02-23
Annual	2022-12-31	1262000000.0	+0.0%	shares	10-K	2025-02-28
Annual	2023-12-31	1258000000.0	-0.3%	shares	10-K	2026-02-24
Annual	2024-12-31	1255000000.0	-0.2%	shares	10-K	2026-02-24
Annual	2025-12-31	1255000000.0	+0.0%	shares	10-K	2026-02-24

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

24,937,000,000

Total Liabilities (latest annual)

N/A

Current Liabilities (latest annual)

11,813,000,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-03-31	0.2544	—	ratio	10-Q	2017-05-10
Quarterly	2016-06-30	0.2170	-14.7%	ratio	10-Q	2017-08-07
Quarterly	2016-09-30	0.1915	-11.7%	ratio	10-Q	2017-11-07
Quarterly	2017-03-31	0.1290	-32.6%	ratio	10-Q	2018-05-09
Quarterly	2017-06-30	0.1329	+3.0%	ratio	10-Q	2018-08-06
Quarterly	2017-09-30	0.1074	-19.2%	ratio	10-Q	2018-11-06
Quarterly	2018-03-31	0.0745	-30.6%	ratio	10-Q	2019-05-08
Quarterly	2018-06-30	0.0837	+12.3%	ratio	10-Q	2019-08-06
Quarterly	2018-09-30	0.0912	+9.0%	ratio	10-Q	2019-11-05
Quarterly	2019-03-31	0.0891	-2.4%	ratio	10-Q	2020-05-06
Quarterly	2019-06-30	0.0824	-7.5%	ratio	10-Q	2020-08-06
Quarterly	2019-09-30	-0.0563	-168.3%	ratio	10-Q	2020-11-04
Quarterly	2020-03-31	0.0693	+223.1%	ratio	10-Q	2021-05-06
Quarterly	2020-06-30	-0.1844	-366.0%	ratio	10-Q	2021-08-05
Quarterly	2020-09-30	0.0202	+111.0%	ratio	10-Q	2021-11-03
Quarterly	2021-03-31	0.0908	+349.4%	ratio	10-Q	2022-05-04
Quarterly	2021-06-30	0.0770	-15.2%	ratio	10-Q	2022-08-08
Quarterly	2021-09-30	0.1204	+56.5%	ratio	10-Q	2022-11-02
Quarterly	2022-03-31	0.0006	-99.5%	ratio	10-Q	2023-05-03
Quarterly	2022-06-30	0.0561	+9218.0%	ratio	10-Q	2023-08-04
Quarterly	2022-09-30	0.0848	+51.1%	ratio	10-Q	2023-11-07
Quarterly	2023-03-31	0.0470	-44.5%	ratio	10-Q	2024-05-08
Quarterly	2023-06-30	0.0493	+4.7%	ratio	10-Q	2024-08-08
Quarterly	2023-09-30	0.0977	+98.3%	ratio	10-Q	2024-11-12
Quarterly	2024-03-31	-0.2389	-344.6%	ratio	10-Q	2025-05-07
Quarterly	2024-06-30	0.0887	+137.1%	ratio	10-Q	2025-08-07
Quarterly	2024-09-30	0.0681	-23.2%	ratio	10-Q	2025-11-07
Quarterly	2025-03-31	0.0689	+1.2%	ratio	10-Q	2025-05-07
Quarterly	2025-06-30	0.1001	+45.2%	ratio	10-Q	2025-08-07
Quarterly	2025-09-30	0.1422	+42.2%	ratio	10-Q	2025-11-07
Annual	2016-12-31	0.6966	—	ratio	10-K	2019-02-26
Annual	2017-12-31	0.2265	-67.5%	ratio	10-K	2020-02-25
Annual	2018-12-31	0.2536	+11.9%	ratio	10-K	2021-02-25
Annual	2019-12-31	0.2368	-6.6%	ratio	10-K	2022-02-23
Annual	2020-12-31	0.0049	-97.9%	ratio	10-K	2023-02-22
Annual	2021-12-31	0.2944	+5927.0%	ratio	10-K	2024-02-23
Annual	2022-12-31	0.2153	-26.9%	ratio	10-K	2025-02-28
Annual	2023-12-31	0.2467	+14.6%	ratio	10-K	2026-02-24
Annual	2024-12-31	0.0249	-89.9%	ratio	10-K	2026-02-24
Annual	2025-12-31	0.3762	+1408.6%	ratio	10-K	2026-02-24

8-K Material Event Details

48 filings · 97 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

782 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-03-27	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	10,000	$136.82	$1,368,162	642,567
2026-03-16	Mercier Johanna	Chief Comm & Corp Aff Officer	Open-market sell S	Common Stock	3,000	$144.23	$432,690	131,779
2026-03-10	Dickinson Andrew D	Chief Financial Officer	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	35,880	$0.00	$0	35,880
2026-03-10	Dickinson Andrew D	Chief Financial Officer	Equity grant / award A · derivative	Restricted Stock Unit	9,590	—	—	30,647
2026-03-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	6,469	—	—	21,057
2026-03-10	Dickinson Andrew D	Chief Financial Officer	Other disposed transaction F	Common Stock	3,147	$148.56	$467,518	182,191
2026-03-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	6,469	—	—	185,338
2026-02-27	Dickinson Andrew D	Chief Financial Officer	Equity grant / award A	Common Stock	11,090	$0.00	$0	178,869
2026-02-17	Mercier Johanna	Chief Comm & Corp Aff Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	25,000	$0.00	$0	48,110
2026-02-17	Mercier Johanna	Chief Comm & Corp Aff Officer	Open-market sell S	Common Stock	200	$155.62	$31,124	120,288
2026-02-17	Mercier Johanna	Chief Comm & Corp Aff Officer	Open-market sell S	Common Stock	9,395	$154.91	$1,455,384	120,488
2026-02-17	Mercier Johanna	Chief Comm & Corp Aff Officer	Open-market sell S	Common Stock	18,405	$154.18	$2,837,720	129,883
2026-02-17	Mercier Johanna	Chief Comm & Corp Aff Officer	Exercise / conversion M	Common Stock	25,000	$66.64	$1,666,000	148,288
2026-02-13	GILEAD SCIENCES, INC.	10%	Open-market buy P · derivative	Prefunded Warrants (right to buy)	3,739,000	$0.53	$1,999,991	40,384,266
2026-02-05	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	115,640	$0.00	$0	0
2026-02-05	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	115,640	$150.00	$17,346,000	613,912
2026-02-05	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	115,640	$66.01	$7,633,396	729,552
2026-02-03	Mercier Johanna	Chief Comm & Corp Aff Officer	Other disposed transaction F	Common Stock	24,800	$143.28	$3,553,344	123,288
2026-02-03	Mercier Johanna	Chief Comm & Corp Aff Officer	Equity grant / award A	Common Stock	44,867	$0.00	$0	148,088
2026-01-28	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	4,968	$140.24	$696,725	556,698
2026-01-28	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	5,032	$139.54	$702,186	561,666
2026-01-23	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	115,640	$0.00	$0	115,640
2026-01-23	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	115,640	$135.00	$15,611,400	566,698
2026-01-23	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	115,640	$66.01	$7,633,396	682,338
2026-01-20	Bluestone Jeffrey	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,000	$0.00	$0	4,665
2026-01-20	Bluestone Jeffrey	Dir	Open-market sell S	Common Stock	5,000	$123.50	$617,500	8,920
2026-01-20	Bluestone Jeffrey	Dir	Exercise / conversion M	Common Stock	5,000	$67.45	$337,250	13,920
2026-01-15	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	3,000	$124.31	$372,930	150,503
2026-01-02	Berger Dietmar	Chief Medical Officer	Exercise / conversion M · derivative	Restricted Stock Unit	16,326	—	—	41,179
2026-01-02	Berger Dietmar	Chief Medical Officer	Other disposed transaction F	Common Stock	6,944	$121.60	$844,390	9,382
2026-01-02	Berger Dietmar	Chief Medical Officer	Exercise / conversion M	Common Stock	16,326	—	—	16,326
2025-12-29	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	10,000	$124.83	$1,248,272	566,698
2025-12-15	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	3,000	$122.00	$366,000	153,503
2025-12-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	3,693	—	—	27,526
2025-12-10	Dickinson Andrew D	Chief Financial Officer	Other disposed transaction F	Common Stock	1,745	$121.34	$211,738	156,503
2025-12-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	3,693	—	—	158,248
2025-11-28	Kramer Kelly A.	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,805	$0.00	$0	0
2025-11-28	Kramer Kelly A.	Dir	Open-market sell S	Common Stock	2,805	$127.10	$356,516	1,339
2025-11-28	Kramer Kelly A.	Dir	Exercise / conversion M	Common Stock	2,805	$81.00	$227,205	4,144
2025-11-28	Bluestone Jeffrey	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,000	$0.00	$0	7,648
2025-11-28	Bluestone Jeffrey	Dir	Open-market sell S	Common Stock	5,000	$125.08	$625,400	8,920
2025-11-28	Bluestone Jeffrey	Dir	Exercise / conversion M	Common Stock	5,000	$64.92	$324,600	13,920
2025-11-26	Kramer Kelly A.	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,806	$0.00	$0	2,805
2025-11-26	Kramer Kelly A.	Dir	Open-market sell S	Common Stock	2,806	$127.11	$356,671	1,339
2025-11-26	Kramer Kelly A.	Dir	Exercise / conversion M	Common Stock	2,806	$81.00	$227,286	4,145
2025-11-17	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	2,500	$125.23	$313,075	154,555
2025-11-12	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	500	$0.00	$0	12,155
2025-11-12	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	35,965	$0.00	$0	12,655
2025-11-12	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	17,181	$0.00	$0	37,799
2025-11-12	Telman Deborah H	EVP, Corporate Affairs & GC	Open-market sell S	Common Stock	500	$122.90	$61,452	43,676
2025-11-12	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	500	$60.75	$30,375	44,176
2025-11-12	Telman Deborah H	EVP, Corporate Affairs & GC	Open-market sell S	Common Stock	35,965	$122.30	$4,398,591	43,676
2025-11-12	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	35,965	$60.75	$2,184,874	79,641
2025-11-12	Telman Deborah H	EVP, Corporate Affairs & GC	Open-market sell S	Common Stock	17,181	$124.00	$2,130,444	43,676
2025-11-12	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	17,181	$75.12	$1,290,637	60,857
2025-10-28	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	2,022	$118.82	$240,259	581,203
2025-10-28	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	7,978	$119.54	$953,667	583,225
2025-10-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	515	—	—	19,816
2025-10-25	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	241	$120.94	$29,147	43,676
2025-10-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	515	—	—	43,917
2025-10-15	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	2,500	$118.08	$295,200	157,055
2025-09-29	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	1,961	$112.42	$220,454	591,203
2025-09-29	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	8,039	$111.47	$896,110	593,164
2025-09-22	Burkhart Erin	SVP, Controllership	Equity grant / award A · derivative	Restricted Stock Unit	8,890	—	—	8,890
2025-09-15	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	3,000	$113.57	$340,710	113,193
2025-09-10	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Unit	10,427	—	—	98,496
2025-09-10	O'Day Daniel Patrick	Chairman & CEO	Other disposed transaction F	Common Stock	4,949	$115.25	$570,372	601,203
2025-09-10	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	10,427	—	—	606,152
2025-08-28	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	10,000	$113.63	$1,136,300	595,725
2025-08-15	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	700	$0.00	$0	98,110
2025-08-15	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	11,800	$0.00	$0	98,810
2025-08-15	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	200	$118.97	$23,793	114,168
2025-08-15	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	2,800	$118.51	$331,821	114,368
2025-08-15	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	700	$118.97	$83,278	117,168
2025-08-15	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M	Common Stock	700	$66.64	$46,648	117,868
2025-08-15	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	11,800	$118.51	$1,398,405	117,168
2025-08-15	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M	Common Stock	11,800	$66.64	$786,352	128,968
2025-08-08	GILEAD SCIENCES, INC.	10%	Open-market buy P · derivative	Class B warrants to purchase Common Stock	1,147,960	—	$24,795,936	1,147,960
2025-08-08	GILEAD SCIENCES, INC.	10%	Open-market buy P · derivative	Class A warrants to purchase Common Stock	1,147,960	—	$24,795,936	1,147,960
2025-08-08	GILEAD SCIENCES, INC.	10%	Open-market buy P	Common Stock	2,295,920	—	—	4,505,391
2025-07-28	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	8,345	$114.09	$952,077	605,725
2025-07-28	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	1,655	$113.17	$187,293	614,070
2025-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	8,229	—	—	21,646
2025-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	514	—	—	29,875
2025-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	3,823	$116.20	$444,233	42,721
2025-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	8,229	—	—	46,544
2025-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	514	—	—	38,315
2025-07-15	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	3,000	$111.03	$333,090	117,168
2025-07-14	Bluestone Jeffrey	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,000	$0.00	$0	9,665
2025-07-14	Bluestone Jeffrey	Dir	Open-market sell S	Common Stock	5,000	$109.74	$548,700	8,920
2025-07-14	Bluestone Jeffrey	Dir	Exercise / conversion M	Common Stock	5,000	$67.45	$337,250	13,920
2025-06-30	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	600	$111.15	$66,688	615,725
2025-06-30	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	9,400	$110.40	$1,037,796	616,325
2025-06-16	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	2,500	$110.17	$275,425	165,110
2025-06-10	Wilfong Diane E.	Interim Corp Controller & CAO	Exercise / conversion M · derivative	Restricted Stock Unit	920	—	—	8,785
2025-06-10	Wilfong Diane E.	Interim Corp Controller & CAO	Other disposed transaction F	Common Stock	340	$110.09	$37,431	45,676
2025-06-10	Wilfong Diane E.	Interim Corp Controller & CAO	Exercise / conversion M	Common Stock	920	—	—	46,016
2025-06-05	GILEAD SCIENCES, INC.	10%	Open-market buy P · derivative	Series C Warrants (right to buy)	13,335,000	—	$10,001,250	13,335,000
2025-06-05	GILEAD SCIENCES, INC.	10%	Open-market buy P · derivative	Series B Warrants (right to buy)	13,335,000	—	$10,001,250	13,335,000
2025-06-05	GILEAD SCIENCES, INC.	10%	Open-market buy P · derivative	Series A Warrants (right to buy)	13,335,000	—	$10,001,250	13,335,000
2025-06-05	GILEAD SCIENCES, INC.	10%	Open-market buy P · derivative	Prefunded Warrants (right to buy)	13,335,000	—	$1,334	23,310,266
2025-05-30	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	3,584	$110.96	$397,696	620,268
2025-05-30	O'Day Daniel Patrick	Chairman & CEO	Open-market sell S	Common Stock	6,416	$110.11	$706,497	623,852
2025-05-22	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	12,500	$0.00	$0	123,110
2025-05-22	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	3,000	$107.52	$322,564	121,152
2025-05-22	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	12,500	$107.52	$1,344,039	124,152
2025-05-22	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M	Common Stock	12,500	$66.64	$833,000	136,652
2025-05-15	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	2,500	$99.82	$249,550	165,674
2025-05-07	Horning Sandra	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	6,809	$0.00	$0	6,809
2025-05-07	Horning Sandra	Dir	Equity grant / award A	Common Stock	1,516	$0.00	$0	5,147
2025-04-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	514	—	—	31,702
2025-04-25	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	158	$103.17	$16,301	36,918
2025-04-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	514	—	—	37,076
2025-04-15	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	2,500	$106.40	$266,000	168,174
2025-03-17	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	2,500	$110.53	$276,325	170,674
2025-03-10	Mercier Johanna	Chief Commercial Officer	Equity grant / award A · derivative	Restricted Stock Unit	11,090	—	—	39,203
2025-03-10	Mercier Johanna	Chief Commercial Officer	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	49,020	$0.00	$0	49,020
2025-03-10	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	8,080	—	—	28,113
2025-03-10	Mercier Johanna	Chief Commercial Officer	Other disposed transaction F	Common Stock	3,907	$117.21	$457,939	124,152
2025-03-10	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M	Common Stock	8,080	—	—	128,059
2025-02-18	GILEAD SCIENCES, INC.	10%	Open-market buy P	Common Stock	1,363,636	$11.00	$14,999,996	31,424,760
2025-02-12	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	18,210	$0.00	$0	0
2025-02-12	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	15,600	$0.00	$0	0
2025-02-12	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	26,175	$0.00	$0	78,515
2025-02-12	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	77,691	$0.00	$0	17,929
2025-02-12	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	137,676	$102.22	$14,073,241	171,223
2025-02-12	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	18,210	$83.49	$1,520,353	308,899
2025-02-12	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	15,600	$80.72	$1,259,232	290,689
2025-02-12	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	26,175	$57.92	$1,516,056	275,089
2025-02-12	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	77,691	$63.91	$4,965,232	248,914
2025-02-04	Patterson Sandra	SVP, Controllership	Equity grant / award A	Common Stock	709	$0.00	$0	37,787
2025-01-31	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	44,160	$0.00	$0	0
2025-01-31	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	71,850	$0.00	$0	0
2025-01-31	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	26,170	$0.00	$0	104,690
2025-01-31	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	142,180	$97.22	$13,822,740	129,873
2025-01-31	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	44,160	$65.38	$2,887,181	273,053
2025-01-31	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	71,850	$72.34	$5,197,629	227,893
2025-01-31	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	26,170	$57.92	$1,515,766	156,043
2025-01-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	515	—	—	27,879
2025-01-25	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	187	$93.07	$17,404	21,640
2025-01-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	515	—	—	21,827
2025-01-15	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	2,500	$91.35	$228,375	129,873
2025-01-02	Berger Dietmar	Chief Medical Officer	Equity grant / award A · derivative	Restricted Stock Unit	48,975	—	—	48,975
2024-12-19	GILEAD SCIENCES, INC.	10%	Open-market buy P	Common Stock	940,499	$21.37	$20,098,464	2,209,471
2024-12-18	GILEAD SCIENCES, INC.	10%	Open-market buy P · derivative	Prefunded Warrants (right to buy)	6,092,816	$1.04	$6,335,919	9,975,266
2024-12-18	GILEAD SCIENCES, INC.	10%	Open-market buy P	Common Stock	1,759,978	$1.04	$1,830,377	9,105,451
2024-12-16	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	8,500	$91.96	$781,660	132,373
2024-12-13	Patterson Sandra	SVP, Controllership	Exercise / conversion M · derivative	Restricted Stock Unit	157	—	—	11,827
2024-12-13	Patterson Sandra	SVP, Controllership	Other disposed transaction F	Common Stock	157	$91.86	$14,421	37,078
2024-12-13	Patterson Sandra	SVP, Controllership	Exercise / conversion M	Common Stock	157	—	—	37,533
2024-12-10	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	639	—	—	28,394
2024-12-10	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	306	$92.34	$28,256	21,312
2024-12-10	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	639	—	—	21,618
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	65,960	$0.00	$0	0
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	43,340	$0.00	$0	0
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	60,885	$0.00	$0	0
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	33,660	$0.00	$0	0
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	18,630	$0.00	$0	0
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	26,170	$0.00	$0	130,860
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	127,930	$92.76	$11,867,119	138,919
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	120,715	$92.77	$11,198,151	266,849
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	65,960	$72.70	$4,795,292	387,564
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	43,340	$72.70	$3,150,818	321,604
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	60,885	$71.91	$4,378,240	278,264
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	33,660	$68.75	$2,314,125	217,379
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	26,170	$57.92	$1,515,766	183,719
2024-11-29	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	18,630	$73.77	$1,374,335	157,549
2024-11-27	Parsey Merdad	Chief Medical Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	88,119	$0.00	$0	196
2024-11-27	Parsey Merdad	Chief Medical Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	57,294	$0.00	$0	64,376
2024-11-27	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	10,399	$92.00	$956,708	80,801
2024-11-27	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	3,199	$91.80	$293,679	91,200
2024-11-27	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	5,200	$91.80	$477,381	94,399
2024-11-27	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	88,119	$92.00	$8,106,948	99,599
2024-11-27	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	57,294	$91.79	$5,259,297	187,718
2024-11-27	Parsey Merdad	Chief Medical Officer	Exercise / conversion M	Common Stock	88,119	$65.38	$5,761,220	245,012
2024-11-27	Parsey Merdad	Chief Medical Officer	Exercise / conversion M	Common Stock	57,294	$57.92	$3,318,468	156,893
2024-11-26	Bluestone Jeffrey	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	4,121	$0.00	$0	11,730
2024-11-26	Bluestone Jeffrey	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,879	$0.00	$0	0
2024-11-26	Bluestone Jeffrey	Dir	Open-market sell S	Common Stock	6,788	$91.39	$620,356	8,920
2024-11-26	Bluestone Jeffrey	Dir	Exercise / conversion M	Common Stock	4,121	$61.35	$252,823	15,708
2024-11-26	Bluestone Jeffrey	Dir	Exercise / conversion M	Common Stock	5,879	$61.17	$359,618	11,587
2024-11-06	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	5,000	$91.28	$456,400	73,127
2024-10-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	514	—	—	29,033
2024-10-25	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	242	$89.00	$21,538	20,979
2024-10-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	514	—	—	21,221
2024-10-01	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	2,000	$83.83	$167,660	100,189
2024-09-12	Parsey Merdad	Chief Medical Officer	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	25,000	$0.00	$0	146,670
2024-09-12	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	21,246	$84.50	$1,795,287	102,189
2024-09-12	Parsey Merdad	Chief Medical Officer	Exercise / conversion M	Common Stock	25,000	$57.92	$1,448,000	123,435
2024-09-10	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	639	—	—	29,547
2024-09-10	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	307	$81.44	$25,002	20,707
2024-09-10	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	639	—	—	21,014
2024-08-28	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	9,513	$78.03	$742,299	105,466
2024-08-13	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	5,490	$73.98	$406,150	114,979
2024-08-10	Patterson Sandra	SVP, Controllership	Exercise / conversion M · derivative	Restricted Stock Unit	3,678	—	—	14,084
2024-08-10	Patterson Sandra	SVP, Controllership	Other disposed transaction F	Common Stock	980	$73.66	$72,187	35,976
2024-08-10	Patterson Sandra	SVP, Controllership	Exercise / conversion M	Common Stock	3,678	—	—	36,956
2024-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	8,230	—	—	30,186
2024-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	514	—	—	38,416
2024-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	8,230	—	—	20,375
2024-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	514	—	—	12,145
2024-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	2,917	$76.51	$223,180	11,631
2024-07-01	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	2,000	$68.63	$137,260	96,380
2024-06-17	GILEAD SCIENCES, INC.	10%	Open-market buy P · derivative	Warrant to purchase Common Stock	179,500	—	$3,051,500	179,500
2024-06-17	GILEAD SCIENCES, INC.	10%	Open-market buy P	Common Stock	179,500	—	—	1,268,972
2024-06-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	3,639	—	—	42,768
2024-06-10	Dickinson Andrew D	Chief Financial Officer	Other disposed transaction F	Common Stock	1,662	$65.25	$108,446	136,960
2024-06-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	3,639	—	—	138,622
2024-05-08	BARTON JACQUELINE K	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	12,648	$0.00	$0	12,648
2024-05-08	BARTON JACQUELINE K	Dir	Equity grant / award A	Common Stock	2,310	$0.00	$0	24,540
2024-04-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	515	—	—	39,568
2024-04-25	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	158	$65.27	$10,313	14,114
2024-04-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	515	—	—	14,272
2024-04-02	GILEAD SCIENCES, INC.	10%	Open-market buy P · derivative	Prefunded Warrants (right to buy)	3,882,450	$0.76	$2,950,274	3,882,450
2024-04-02	GILEAD SCIENCES, INC.	10%	Open-market buy P	Common Stock	485,250	$0.76	$368,790	7,345,473
2024-04-01	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	2,000	$72.96	$145,920	96,304
2024-03-28	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	34	$0.00	$0	3,258
2024-03-10	Telman Deborah H	EVP, Corporate Affairs & GC	Equity grant / award A · derivative	Restricted Stock Unit	10,815	—	—	40,083
2024-03-10	Telman Deborah H	EVP, Corporate Affairs & GC	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	54,980	$0.00	$0	54,980
2024-03-10	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	2,555	—	—	29,268
2024-03-10	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	846	$75.12	$63,552	13,757
2024-03-10	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	2,555	—	—	14,603
2024-02-29	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	8,230	$72.74	$598,624	92,706
2024-02-28	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	2,000	$73.18	$146,360	100,936
2024-02-12	GILEAD SCIENCES, INC.	10%	Exercise / conversion C · derivative	Series B Convertible Preferred Stock	7,746,139	$0.00	$0	0
2024-02-12	GILEAD SCIENCES, INC.	10%	Exercise / conversion C · derivative	Series A-2 Convertible Preferred Stock	6,890,744	$0.00	$0	0
2024-02-12	GILEAD SCIENCES, INC.	10%	Open-market buy P	Common Stock	910,000	$22.00	$20,020,000	4,126,119
2024-02-12	GILEAD SCIENCES, INC.	10%	Exercise / conversion C	Common Stock	3,216,119	—	—	3,216,119
2024-02-02	LOVE TED W	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	2,996	$0.00	$0	2,996
2024-02-02	LOVE TED W	Dir	Equity grant / award A	Common Stock	512	$0.00	$0	512
2024-01-31	Parsey Merdad	Chief Medical Officer	Other disposed transaction F	Common Stock	23,709	$78.26	$1,855,466	102,616
2024-01-31	Parsey Merdad	Chief Medical Officer	Equity grant / award A	Common Stock	56,624	$0.00	$0	126,325
2024-01-31	Parsey Merdad	Chief Medical Officer	Equity grant / award A	Common Stock	20,229	$0.00	$0	69,701
2024-01-29	GILEAD SCIENCES, INC.	10%	Open-market buy P	Common Stock	15,238,095	$21.00	$319,999,995	30,061,124
2024-01-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	514	—	—	31,823
2024-01-25	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	194	$80.23	$15,565	7,082
2024-01-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	514	—	—	7,276
2024-01-16	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	5,000	$85.78	$428,900	101,534
2024-01-09	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	8,242	$85.23	$702,466	82,729
2023-12-28	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	30	$0.00	$0	3,224
2023-12-13	Patterson Sandra	SVP, Controllership	Exercise / conversion M · derivative	Restricted Stock Unit	117	—	—	11,984
2023-12-13	Patterson Sandra	SVP, Controllership	Exercise / conversion M · derivative	Restricted Stock Unit	181	—	—	12,101
2023-12-13	Patterson Sandra	SVP, Controllership	Other disposed transaction F	Common Stock	298	$83.09	$24,761	37,235
2023-12-13	Patterson Sandra	SVP, Controllership	Exercise / conversion M	Common Stock	117	—	—	37,376
2023-12-13	Patterson Sandra	SVP, Controllership	Exercise / conversion M	Common Stock	181	—	—	37,259
2023-12-10	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	2,730	—	—	39,987
2023-12-10	Mercier Johanna	Chief Commercial Officer	Other disposed transaction F	Common Stock	1,247	$79.02	$98,538	90,971
2023-12-10	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M	Common Stock	2,730	—	—	92,218
2023-11-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	1,912	—	—	41,451
2023-11-10	Dickinson Andrew D	Chief Financial Officer	Other disposed transaction F	Common Stock	804	$75.92	$61,040	105,111
2023-11-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	1,912	—	—	105,915
2023-10-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	514	—	—	32,337
2023-10-25	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	243	$78.39	$19,049	6,762
2023-10-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	514	—	—	7,005
2023-10-17	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	5,000	$80.00	$400,017	104,003
2023-09-28	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	31	$0.00	$0	3,195
2023-09-12	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	1,501	$76.99	$115,562	70,130
2023-09-10	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	2,730	—	—	42,717
2023-09-10	Mercier Johanna	Chief Commercial Officer	Other disposed transaction F	Common Stock	1,256	$76.00	$95,456	89,488
2023-09-10	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M	Common Stock	2,730	—	—	90,744
2023-08-10	Patterson Sandra	SVP, Controllership	Exercise / conversion M · derivative	Restricted Stock Unit	4,484	—	—	17,557
2023-08-10	Patterson Sandra	SVP, Controllership	Other disposed transaction F	Common Stock	1,306	$80.00	$104,480	29,754
2023-08-10	Patterson Sandra	SVP, Controllership	Exercise / conversion M	Common Stock	4,484	—	—	31,060
2023-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	2,058	—	—	32,851
2023-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M · derivative	Restricted Stock Unit	8,231	—	—	34,909
2023-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	2,058	—	—	6,491
2023-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Other disposed transaction F	Common Stock	4,174	$77.23	$322,358	4,433
2023-07-25	Telman Deborah H	EVP, Corporate Affairs & GC	Exercise / conversion M	Common Stock	8,231	—	—	8,607
2023-07-24	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	7,505	—	—	45,447
2023-07-24	Mercier Johanna	Chief Commercial Officer	Other disposed transaction F	Common Stock	3,174	$77.66	$246,493	48,326
2023-07-24	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M	Common Stock	7,505	—	—	51,500
2023-07-20	Dickinson Andrew D	Chief Financial Officer	Open-market sell S	Common Stock	5,000	$80.00	$400,000	107,587
2023-06-29	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	31	$0.00	$0	3,163
2023-06-28	GILEAD SCIENCES, INC.	10%	Open-market buy P	Common Stock	1,010,000	$19.26	$19,452,600	14,823,029
2023-06-27	GILEAD SCIENCES, INC.	10%	Open-market buy P	Common Stock	2,930,870	$3.75	$10,990,762	16,635,286
2023-06-13	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	1,485	$76.90	$114,196	29,402
2023-06-10	Patterson Sandra	SVP, Controllership	Exercise / conversion M · derivative	Restricted Stock Unit	517	—	—	22,041
2023-06-10	Patterson Sandra	SVP, Controllership	Other disposed transaction F	Common Stock	153	$78.12	$11,952	26,576
2023-06-10	Patterson Sandra	SVP, Controllership	Exercise / conversion M	Common Stock	517	—	—	26,729
2023-05-03	Kramer Kelly A.	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	10,173	$79.45	$808,245	10,173
2023-05-03	Kramer Kelly A.	Dir	Equity grant / award A · derivative	Restricted Stock Unit	1,887	—	—	15,284
2023-05-01	Lofton Kevin E	Dir	Equity grant / award G	Common Stock	12,868	$0.00	$0	90,766
2023-03-30	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	29	$0.00	$0	3,132
2023-03-13	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	6,126	$78.99	$483,893	70,130
2023-03-10	O'Day Daniel Patrick	Chairman & CEO	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	215,095	$0.00	$0	215,095
2023-03-10	O'Day Daniel Patrick	Chairman & CEO	Equity grant / award A · derivative	Restricted Stock Unit	47,170	—	—	132,933
2023-03-10	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Unit	10,800	—	—	85,763
2023-03-10	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Unit	19,488	—	—	96,563
2023-03-10	O'Day Daniel Patrick	Chairman & CEO	Other disposed transaction F	Common Stock	14,017	$79.50	$1,114,352	375,766
2023-03-10	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	10,800	—	—	389,783
2023-03-10	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	19,488	—	—	378,983
2023-03-09	Lofton Kevin E	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,442	$0.00	$0	0
2023-03-09	Lofton Kevin E	Dir	Exercise / conversion M	Common Stock	8,442	$52.38	$442,192	8,442
2023-03-01	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	12,984	$79.96	$1,038,225	70,130
2023-02-15	Dickinson Andrew D	Chief Financial Officer	Equity grant / award A	Common Stock	376	$56.38	$21,199	105,618
2023-02-06	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M · derivative	Restricted Stock Unit	1,864	—	—	11,060
2023-02-06	Wilfong Diane E.	SVP, Controller & CAO	Other disposed transaction F	Common Stock	565	$86.36	$48,793	32,010
2023-02-06	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M	Common Stock	1,864	—	—	32,575
2023-01-24	Dickinson Andrew D	Chief Financial Officer	Other disposed transaction F	Common Stock	15,327	$84.02	$1,287,775	103,956
2023-01-24	Dickinson Andrew D	Chief Financial Officer	Equity grant / award A	Common Stock	38,270	$0.00	$0	119,283
2023-01-24	Dickinson Andrew D	Chief Financial Officer	Equity grant / award A	Common Stock	27,932	$0.00	$0	81,013
2022-12-30	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	553	$85.33	$47,187	45,556
2022-12-29	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	26	$0.00	$0	3,104
2022-12-10	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M · derivative	Restricted Stock Unit	318	—	—	12,924
2022-12-10	Wilfong Diane E.	SVP, Controller & CAO	Other disposed transaction F	Common Stock	149	$87.97	$13,108	28,502
2022-12-10	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M	Common Stock	318	—	—	28,651
2022-11-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	1,912	—	—	45,513
2022-11-10	Dickinson Andrew D	Chief Financial Officer	Other disposed transaction F	Common Stock	851	$82.60	$70,293	68,668
2022-11-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	1,912	—	—	69,519
2022-11-09	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	6,416	$0.00	$0	10,694
2022-11-09	Wilfong Diane E.	SVP, Controller & CAO	Open-market sell S	Common Stock	6,416	$83.50	$535,736	28,333
2022-11-09	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M	Common Stock	6,416	$63.91	$410,047	34,749
2022-11-01	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	16,255	$0.00	$0	0
2022-11-01	Wilfong Diane E.	SVP, Controller & CAO	Open-market sell S	Common Stock	16,255	$79.25	$1,288,209	28,333
2022-11-01	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M	Common Stock	16,255	$72.70	$1,181,738	44,588
2022-09-29	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	35	$0.00	$0	3,077
2022-09-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	1,027	—	—	47,425
2022-09-10	Dickinson Andrew D	Chief Financial Officer	Other disposed transaction F	Common Stock	476	$65.28	$31,073	67,607
2022-09-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	1,027	—	—	68,083
2022-08-10	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M · derivative	Restricted Stock Unit	2,479	—	—	13,560
2022-08-10	Wilfong Diane E.	SVP, Controller & CAO	Other disposed transaction F	Common Stock	1,066	$63.14	$67,307	28,163
2022-08-10	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M	Common Stock	2,479	—	—	29,229
2022-07-24	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	7,505	—	—	52,288
2022-07-24	Mercier Johanna	Chief Commercial Officer	Other disposed transaction F	Common Stock	3,206	$60.80	$194,925	39,371
2022-07-24	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M	Common Stock	7,505	—	—	42,577
2022-06-29	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	35	$0.00	$0	3,042
2022-06-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	1,026	—	—	48,452
2022-06-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	3,646	—	—	49,478
2022-06-10	Dickinson Andrew D	Chief Financial Officer	Other disposed transaction F	Common Stock	1,969	$60.74	$119,597	67,056
2022-06-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	1,026	—	—	69,025
2022-06-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	3,646	—	—	67,999
2022-05-05	BARTON JACQUELINE K	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	15,851	$0.00	$0	15,851
2022-05-05	BARTON JACQUELINE K	Dir	Equity grant / award A	Common Stock	2,444	$0.00	$0	20,343
2022-05-03	BARTON JACQUELINE K	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	2,223	—	—	4,553
2022-05-03	BARTON JACQUELINE K	Dir	Exercise / conversion M	Common Stock	2,223	—	—	17,899
2022-04-28	Lofton Kevin E	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	16,322	$0.00	$0	0
2022-04-28	Lofton Kevin E	Dir	Exercise / conversion M	Common Stock	16,322	$25.62	$418,251	90,525
2022-03-30	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	36	$0.00	$0	3,007
2022-03-10	Dickinson Andrew D	Chief Financial Officer	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	157,030	$0.00	$0	157,030
2022-03-10	Dickinson Andrew D	Chief Financial Officer	Equity grant / award A · derivative	Restricted Stock Unit	25,465	—	—	53,124
2022-03-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	4,108	—	—	27,659
2022-03-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	3,025	—	—	31,767
2022-03-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	768	—	—	34,792
2022-03-10	Dickinson Andrew D	Chief Financial Officer	Other disposed transaction F	Common Stock	3,602	$57.92	$208,628	64,005
2022-03-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	4,108	—	—	67,607
2022-03-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	3,025	—	—	63,499
2022-03-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	768	—	—	60,474
2022-03-01	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Unit	42,922	—	—	96,572
2022-03-01	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Unit	11,362	—	—	139,494
2022-03-01	O'Day Daniel Patrick	Chairman & CEO	Other disposed transaction F	Common Stock	23,245	$60.26	$1,400,744	236,393
2022-03-01	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	42,922	—	—	259,638
2022-03-01	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	11,362	—	—	216,716
2022-02-15	Dickinson Andrew D	Chief Financial Officer	Equity grant / award A	Common Stock	348	$52.13	$18,141	64,353
2022-02-09	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	1,691	$63.89	$108,038	32,576
2022-02-06	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	1,817	—	—	35,560
2022-02-06	Dickinson Andrew D	Chief Financial Officer	Other disposed transaction F	Common Stock	767	$63.90	$49,011	59,706
2022-02-06	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	1,817	$0.00	$0	60,473
2022-02-01	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	14,061	$68.54	$963,682	32,576
2022-01-26	Mercier Johanna	Chief Commercial Officer	Equity grant / award A	Common Stock	18,630	$0.00	$0	30,778
2021-12-30	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	28	$0.00	$0	2,971
2021-12-08	Bluestone Jeffrey	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	1,041	—	—	2,223
2021-12-08	Bluestone Jeffrey	Dir	Exercise / conversion M	Common Stock	1,041	—	—	1,041
2021-11-10	Parsey Merdad	Chief Medical Officer	Exercise / conversion M · derivative	Restricted Stock Unit	5,100	—	—	32,089
2021-11-10	Parsey Merdad	Chief Medical Officer	Other disposed transaction F	Common Stock	2,320	$67.32	$156,182	16,860
2021-11-10	Parsey Merdad	Chief Medical Officer	Exercise / conversion M	Common Stock	5,100	—	—	19,180
2021-10-22	WELTERS ANTHONY	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	1,368	—	—	2,223
2021-10-22	WELTERS ANTHONY	Dir	Exercise / conversion M	Common Stock	1,368	—	—	1,368
2021-09-29	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	29	$0.00	$0	2,942
2021-08-17	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	3,829	$0.00	$0	0
2021-08-17	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,781	$0.00	$0	5,869
2021-08-17	Wilfong Diane E.	SVP, Controller & CAO	Open-market sell S	Common Stock	13,610	$72.50	$986,725	20,398
2021-08-17	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M	Common Stock	3,829	$66.36	$254,092	34,008
2021-08-17	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M	Common Stock	9,781	$68.75	$672,444	30,179
2021-08-15	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Equity grant / award A	Common Stock	32	$55.08	$1,763	29,198
2021-08-10	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M · derivative	Restricted Stock Unit	2,480	—	—	15,907
2021-08-10	Wilfong Diane E.	SVP, Controller & CAO	Other disposed transaction F	Common Stock	907	$69.24	$62,801	20,398
2021-08-10	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M	Common Stock	2,480	—	—	21,305
2021-07-24	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	7,505	—	—	39,930
2021-07-24	Mercier Johanna	Chief Commercial Officer	Other disposed transaction F	Common Stock	3,425	$69.02	$236,394	12,148
2021-07-24	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M	Common Stock	7,505	—	—	15,573
2021-06-29	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	30	$0.00	$0	2,913
2021-06-15	Rodriguez Javier	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	1,838	—	—	2,223
2021-06-15	Rodriguez Javier	Dir	Exercise / conversion M	Common Stock	1,838	—	—	1,838
2021-06-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	3,646	—	—	39,290
2021-06-10	Dickinson Andrew D	Chief Financial Officer	Other disposed transaction F	Common Stock	1,605	$69.29	$111,210	36,971
2021-06-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	3,646	—	—	38,576
2021-05-12	BARTON JACQUELINE K	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	14,665	$0.00	$0	14,665
2021-05-12	BARTON JACQUELINE K	Dir	Equity grant / award A · derivative	Restricted Stock Unit	2,223	—	—	6,776
2021-05-06	WOLD OLSEN PER	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	1,936	—	—	0
2021-05-06	WOLD OLSEN PER	Dir	Exercise / conversion M	Common Stock	1,936	—	—	102,060
2021-05-04	Mercier Johanna	Chief Commercial Officer	Open-market sell S	Common Stock	19,496	$66.09	$1,288,547	8,068
2021-05-03	Whitley Richard James	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	20,282	$0.00	$0	0
2021-05-03	Whitley Richard James	Dir	Open-market sell S	Common Stock	20,282	$64.57	$1,309,655	31,122
2021-05-03	Whitley Richard James	Dir	Exercise / conversion M	Common Stock	20,282	$20.64	$418,722	51,404
2021-03-30	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	31	$0.00	$0	2,883
2021-03-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	3,794	—	—	42,936
2021-03-10	Dickinson Andrew D	Chief Financial Officer	Equity grant / award A · derivative	Restricted Stock Unit	16,430	—	—	46,730
2021-03-10	Dickinson Andrew D	Chief Financial Officer	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	95,620	$63.91	$6,111,074	95,620
2021-03-10	Dickinson Andrew D	Chief Financial Officer	Other disposed transaction F	Common Stock	1,771	$63.91	$113,185	34,930
2021-03-10	Dickinson Andrew D	Chief Financial Officer	Exercise / conversion M	Common Stock	3,794	—	—	36,701
2021-03-10	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Unit	10,800	—	—	150,856
2021-03-10	O'Day Daniel Patrick	Chairman & CEO	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	307,355	$63.91	$19,643,058	307,355
2021-03-10	O'Day Daniel Patrick	Chairman & CEO	Equity grant / award A · derivative	Restricted Stock Unit	52,810	—	—	161,656
2021-03-10	O'Day Daniel Patrick	Chairman & CEO	Other disposed transaction F	Common Stock	5,123	$63.91	$327,411	142,013
2021-03-10	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	10,800	—	—	147,136
2021-03-10	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Unit	10,800	—	—	150,856
2021-03-10	O'Day Daniel Patrick	Chairman & CEO	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	307,355	$0.00	$0	307,355
2021-03-10	O'Day Daniel Patrick	Chairman & CEO	Equity grant / award A · derivative	Restricted Stock Unit	52,810	—	—	161,656
2021-03-10	O'Day Daniel Patrick	Chairman & CEO	Other disposed transaction F	Common Stock	5,123	$63.91	$327,411	142,013
2021-03-10	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	10,800	—	—	147,136
2021-03-01	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Unit	11,363	—	—	108,846
2021-03-01	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Unit	42,923	—	—	120,209
2021-03-01	O'Day Daniel Patrick	Chairman & CEO	Other disposed transaction F	Common Stock	24,620	$62.46	$1,537,765	136,336
2021-03-01	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	11,363	—	—	160,956
2021-03-01	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	42,923	—	—	149,593
2021-02-15	Dickinson Andrew D	Chief Financial Officer	Equity grant / award A	Common Stock	364	$56.86	$20,696	32,907
2021-02-10	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M · derivative	Restricted Stock Unit	778	—	—	15,327
2021-02-10	Wilfong Diane E.	SVP, Controller & CAO	Other disposed transaction F	Common Stock	197	$67.29	$13,256	17,409
2021-02-10	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M	Common Stock	778	$0.00	$0	17,606
2021-02-06	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M · derivative	Restricted Stock Unit	1,866	—	—	16,105
2021-02-06	Wilfong Diane E.	SVP, Controller & CAO	Other disposed transaction F	Common Stock	533	$68.46	$36,489	16,828
2021-02-06	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M	Common Stock	1,866	$0.00	$0	17,361
2021-02-01	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	9,711	$65.97	$640,633	28,832
2021-01-31	GILEAD SCIENCES INC	10%	Open-market buy P	Common Stock	5,650,000	$39.00	$220,350,000	13,913,029
2021-01-28	Horning Sandra	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	632	—	—	1,936
2021-01-28	Horning Sandra	Dir	Exercise / conversion M	Common Stock	632	—	—	632
2021-01-26	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Other disposed transaction F	Common Stock	3,736	$66.70	$249,191	38,543
2021-01-26	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Equity grant / award A	Common Stock	13,447	$0.00	$0	42,279
2021-01-26	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Equity grant / award A	Common Stock	14,188	$0.00	$0	28,832
2021-01-22	Lofton Kevin E	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	20,282	$0.00	$0	0
2021-01-22	Lofton Kevin E	Dir	Exercise / conversion M	Common Stock	20,282	$20.64	$418,722	74,203
2020-12-30	Whitley Richard James	Dir	Equity grant / award A · derivative	Phantom Stock	69	$0.00	$0	5,809
2020-12-08	Bluestone Jeffrey	Dir	Equity grant / award A · derivative	Restricted Stock Unit	1,041	—	—	1,041
2020-12-08	Bluestone Jeffrey	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	5,879	$0.00	$0	5,879
2020-11-23	Lofton Kevin E	Dir	Equity grant / award G	Common Stock	21,720	$0.00	$0	53,921
2020-11-10	Dickinson Andrew D	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	1,913	—	—	32,118
2020-11-10	Dickinson Andrew D	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	1,133	—	—	34,031
2020-11-10	Dickinson Andrew D	EVP, Chief Financial Officer	Other disposed transaction F	Common Stock	1,399	$60.62	$84,807	16,286
2020-11-10	Dickinson Andrew D	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock	1,913	—	—	17,685
2020-11-10	Dickinson Andrew D	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock	1,133	—	—	15,772
2020-11-03	Mercier Johanna	Chief Commercial Officer	Other disposed transaction F	Common Stock	12,282	$58.83	$722,550	17,906
2020-11-03	Mercier Johanna	Chief Commercial Officer	Equity grant / award A	Common Stock	26,270	$0.00	$0	30,188
2020-10-22	WELTERS ANTHONY	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	7,718	$0.00	$0	7,718
2020-10-22	WELTERS ANTHONY	Dir	Equity grant / award A · derivative	Restricted Stock Unit	1,368	—	—	1,368
2020-10-01	Whitley Richard James	Dir	Exercise / conversion M · derivative	Phantom Stock	1,434	$0.00	$0	5,740
2020-10-01	Whitley Richard James	Dir	Exercise / conversion M	Common Stock	1,434	$0.00	$0	31,122
2020-09-29	Whitley Richard James	Dir	Equity grant / award A · derivative	Phantom Stock	78	$0.00	$0	7,175
2020-08-17	Parsey Merdad	Chief Medical Officer	Open-market sell S	Common Stock	182	$68.32	$12,434	0
2020-08-15	Parsey Merdad	Chief Medical Officer	Equity grant / award A	Common Stock	182	$57.43	$10,452	182
2020-08-10	Dickinson Andrew D	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	2,306	—	—	35,164
2020-08-10	Dickinson Andrew D	EVP, Chief Financial Officer	Other disposed transaction F	Common Stock	1,022	$68.51	$70,017	14,639
2020-08-10	Dickinson Andrew D	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock	2,306	—	—	15,661
2020-07-24	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	7,505	$0.00	$0	34,615
2020-07-24	Mercier Johanna	Chief Commercial Officer	Other disposed transaction F	Common Stock	3,587	$73.64	$264,147	3,918
2020-07-24	Mercier Johanna	Chief Commercial Officer	Exercise / conversion M	Common Stock	7,505	$0.00	$0	7,505
2020-06-29	Whitley Richard James	Dir	Equity grant / award A · derivative	Phantom Stock	64	$0.00	$0	7,097
2020-06-23	Rodriguez Javier	Dir	Open-market sell S	Common Stock	189	$75.50	$14,270	0
2020-06-15	Rodriguez Javier	Dir	Equity grant / award A · derivative	Restricted Stock Unit	1,838	—	—	1,838
2020-06-15	Rodriguez Javier	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	8,667	$0.00	$0	8,667
2020-06-10	Dickinson Andrew D	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	3,646	$0.00	$0	37,470
2020-06-10	Dickinson Andrew D	EVP, Chief Financial Officer	Other disposed transaction F	Common Stock	1,691	$77.07	$130,325	13,355
2020-06-10	Dickinson Andrew D	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock	3,646	$0.00	$0	15,046
2020-05-06	MANWANI HARISH	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	7,886	$0.00	$0	7,886
2020-05-06	MANWANI HARISH	Dir	Equity grant / award A · derivative	Restricted Stock Unit	1,936	—	—	1,936
2020-05-06	BARTON JACQUELINE K	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	7,886	$0.00	$0	7,886
2020-05-06	BARTON JACQUELINE K	Dir	Equity grant / award A · derivative	Restricted Stock Unit	1,936	—	—	6,489
2020-05-05	MANWANI HARISH	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	2,270	—	—	0
2020-05-05	MANWANI HARISH	Dir	Other disposed transaction F	Common Stock	419	$79.14	$33,160	3,718
2020-05-05	MANWANI HARISH	Dir	Exercise / conversion M	Common Stock	2,270	—	—	4,137
2020-05-04	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	11,486	$0.00	$0	3,829
2020-05-04	Wilfong Diane E.	SVP, Controller & CAO	Open-market sell S	Common Stock	12,264	$80.09	$982,220	11,421
2020-05-04	Wilfong Diane E.	SVP, Controller & CAO	Exercise / conversion M	Common Stock	11,486	$66.36	$762,211	23,685
2020-04-27	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,413	$0.00	$0	2,416
2020-04-27	Cogan John Francis	Dir	Open-market sell S	Common Stock	2,413	$79.90	$192,799	54,860
2020-04-27	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	2,413	$19.63	$47,367	57,273
2020-04-20	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,413	$0.00	$0	4,829
2020-04-20	Cogan John Francis	Dir	Open-market sell S	Common Stock	2,413	$83.00	$200,279	54,860
2020-04-20	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	2,413	$19.63	$47,367	57,273
2020-04-13	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,413	$0.00	$0	7,242
2020-04-13	Cogan John Francis	Dir	Open-market sell S	Common Stock	2,413	$75.90	$183,147	54,860
2020-04-13	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	2,413	$19.63	$47,367	57,273
2020-04-06	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,413	$0.00	$0	9,655
2020-04-06	Cogan John Francis	Dir	Open-market sell S	Common Stock	2,413	$79.52	$191,882	54,860
2020-04-06	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	2,413	$19.63	$47,367	57,273
2020-03-30	Whitley Richard James	Dir	Equity grant / award A · derivative	Phantom Stock	62	$0.00	$0	7,033
2020-03-23	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,413	$0.00	$0	14,481
2020-03-23	Cogan John Francis	Dir	Open-market sell S	Common Stock	2,413	$75.27	$181,627	54,860
2020-03-23	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	2,413	$19.63	$47,367	57,273
2020-03-16	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,413	$0.00	$0	16,894
2020-03-16	Cogan John Francis	Dir	Open-market sell S	Common Stock	2,413	$67.26	$162,298	54,860
2020-03-16	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	2,413	$19.63	$47,367	57,273
2020-03-10	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Equity grant / award A · derivative	Restricted Stock Unit	10,370	—	—	18,552
2020-03-10	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	61,590	$0.00	$0	61,590
2020-03-10	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,950	$0.00	$0	650
2020-03-10	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	2,950	$75.55	$222,872	14,644
2020-03-10	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M	Common Stock	2,950	$24.30	$71,670	17,594
2020-03-09	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,413	$0.00	$0	19,307
2020-03-09	Cogan John Francis	Dir	Open-market sell S	Common Stock	2,413	$77.97	$188,142	54,860
2020-03-09	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	2,413	$19.63	$47,367	57,273
2020-03-02	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	1,100	$71.26	$78,383	14,644
2020-03-02	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	9,341	$70.83	$661,630	15,744
2020-03-01	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Unit	42,925	—	—	119,932
2020-03-01	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M · derivative	Restricted Stock Unit	11,363	—	—	162,857
2020-03-01	O'Day Daniel Patrick	Chairman & CEO	Other disposed transaction F	Common Stock	25,922	$69.36	$1,797,950	47,570
2020-03-01	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	42,925	—	—	73,492
2020-03-01	O'Day Daniel Patrick	Chairman & CEO	Exercise / conversion M	Common Stock	11,363	—	—	30,567
2020-02-24	Lofton Kevin E	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	21,720	$0.00	$0	0
2020-02-24	Lofton Kevin E	Dir	Exercise / conversion M	Common Stock	21,720	$19.63	$426,364	86,579
2020-02-15	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Equity grant / award A	Common Stock	395	$53.67	$21,199	25,085
2020-02-10	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,950	$0.00	$0	3,600
2020-02-10	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	2,950	$69.32	$204,494	24,690
2020-02-10	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M	Common Stock	2,950	$24.30	$71,670	27,640
2020-02-07	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	1,426	$70.00	$99,820	24,690
2020-02-06	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M · derivative	Restricted Stock Unit	2,728	—	—	8,182
2020-02-06	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,000	$0.00	$0	12,560
2020-02-06	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Other disposed transaction F	Common Stock	1,302	$68.21	$88,809	26,116
2020-02-06	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M	Common Stock	2,728	—	—	27,418
2020-02-06	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	5,000	$68.18	$340,900	24,690
2020-02-06	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M	Common Stock	5,000	$40.56	$202,800	29,690
2020-01-29	O'Day Daniel Patrick	Chairman & CEO	Equity grant / award A	Common Stock	19,204	$0.00	$0	19,204
2020-01-28	Horning Sandra	Dir	Equity grant / award A · derivative	Restricted Stock Unit	632	—	—	632
2020-01-28	Horning Sandra	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	3,837	$0.00	$0	3,837
2020-01-03	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,950	$0.00	$0	6,550
2020-01-03	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	2,950	$64.63	$190,658	17,064
2020-01-03	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M	Common Stock	2,950	$24.30	$71,670	20,014
2019-12-30	Whitley Richard James	Dir	Equity grant / award A · derivative	Phantom Stock	67	$0.00	$0	6,971
2019-12-03	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,900	$0.00	$0	9,500
2019-12-03	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	5,900	$65.77	$388,043	17,064
2019-12-03	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M	Common Stock	5,900	$24.30	$143,340	22,964
2019-11-27	Lofton Kevin E	Dir	Other disposed transaction J	Common Stock	13,208	$0.00	$0	75,641
2019-11-25	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	15,000	$0.00	$0	17,560
2019-11-25	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	15,000	$66.85	$1,002,808	17,064
2019-11-25	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M	Common Stock	15,000	$40.56	$608,400	32,064
2019-11-19	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	10,000	$0.00	$0	15,400
2019-11-19	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	10,000	$64.91	$649,062	17,064
2019-11-19	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M	Common Stock	10,000	$24.30	$242,950	27,064
2019-11-18	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	10,000	$0.00	$0	25,400
2019-11-18	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	10,000	$63.85	$638,500	17,064
2019-11-18	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M	Common Stock	10,000	$24.30	$242,950	27,064
2019-11-14	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Equity grant / award G	Common Stock	762	$0.00	$0	17,064
2019-11-10	Dickinson Andrew D	EVP, Chief Financial Officer	Exercise / conversion M · derivative	Restricted Stock Unit	1,133	—	—	3,439
2019-11-10	Dickinson Andrew D	EVP, Chief Financial Officer	Equity grant / award A · derivative	Restricted Stock Unit	7,650	—	—	28,164
2019-11-10	Dickinson Andrew D	EVP, Chief Financial Officer	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	44,160	$0.00	$0	44,160
2019-11-10	Dickinson Andrew D	EVP, Chief Financial Officer	Other disposed transaction F	Common Stock	521	$65.38	$34,063	5,539
2019-11-10	Dickinson Andrew D	EVP, Chief Financial Officer	Exercise / conversion M	Common Stock	1,133	—	—	6,060
2019-11-05	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	2,095	$66.06	$138,404	17,826
2019-11-01	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,400	$0.00	$0	0
2019-11-01	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Open-market sell S	Common Stock	4,000	$64.52	$258,099	19,921
2019-11-01	Pletcher Brett A	EVP,Corp Affairs & Gen Counsel	Exercise / conversion M	Common Stock	2,400	$16.89	$40,536	23,921
2019-10-28	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Open-market sell S	Common Stock	5,677	$63.31	$359,412	21,521
2019-10-01	Lofton Kevin E	Dir	Exercise / conversion M · derivative	Phantom Stock	21,527	$0.00	$0	2,711
2019-10-01	Lofton Kevin E	Dir	Exercise / conversion M	Common Stock	21,527	$0.00	$0	64,859
2019-09-27	Whitley Richard James	Dir	Equity grant / award A · derivative	Phantom Stock	68	$0.00	$0	6,904
2019-08-28	WOLD OLSEN PER	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	4,908	$0.00	$0	0
2019-08-28	WOLD OLSEN PER	Dir	Open-market sell S	Common Stock	4,908	$63.91	$313,671	97,854
2019-08-28	WOLD OLSEN PER	Dir	Exercise / conversion M	Common Stock	4,908	$23.75	$116,590	102,762
2019-08-19	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Open-market sell S	Common Stock	608	$64.35	$39,123	27,198
2019-08-10	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Exercise / conversion M · derivative	Restricted Stock Unit	1,070	—	—	10,910
2019-08-10	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Other disposed transaction F	Common Stock	462	$65.24	$30,141	27,806
2019-08-10	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Exercise / conversion M	Common Stock	1,070	—	—	28,268
2019-07-24	Mercier Johanna	Chief Commercial Officer	Equity grant / award A · derivative	Restricted Stock Unit	30,020	—	—	30,020
2019-07-24	Mercier Johanna	Chief Commercial Officer	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	148,110	$0.00	$0	148,110
2019-07-23	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	7,200	$0.00	$0	0
2019-07-23	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Open-market sell S	Common Stock	7,200	$65.07	$468,504	27,198
2019-07-23	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Exercise / conversion M	Common Stock	7,200	$24.91	$179,316	34,398
2019-06-27	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	223	$0.00	$0	23,999
2019-06-18	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Open-market sell S	Common Stock	5,816	$68.75	$399,850	27,198
2019-05-08	Hamill Laura	EVP, Worldwide Commercial Ops	Other disposed transaction F	Common Stock	3,500	$66.07	$231,245	6,340
2019-05-08	Hamill Laura	EVP, Worldwide Commercial Ops	Equity grant / award A	Common Stock	9,840	$0.00	$0	9,840
2019-05-07	WOLD OLSEN PER	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	2,283	—	—	0
2019-05-07	WOLD OLSEN PER	Dir	Exercise / conversion M	Common Stock	2,283	—	—	97,854
2019-05-01	Whitley Richard James	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,534	$0.00	$0	0
2019-05-01	Whitley Richard James	Dir	Open-market sell S	Common Stock	9,534	$65.02	$619,934	25,135
2019-05-01	Whitley Richard James	Dir	Exercise / conversion M	Common Stock	9,534	$22.02	$209,891	34,669
2019-04-24	Lofton Kevin E	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	13,208	$0.00	$0	0
2019-04-24	Lofton Kevin E	Dir	Exercise / conversion M	Common Stock	13,208	$24.91	$328,945	43,332
2019-04-17	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,700	$0.00	$0	5,568
2019-04-17	Cogan John Francis	Dir	Open-market sell S	Common Stock	100	$64.66	$6,466	54,860
2019-04-17	Cogan John Francis	Dir	Open-market sell S	Common Stock	2,600	$64.21	$166,958	54,960
2019-04-17	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	2,700	$22.02	$59,440	57,560
2019-04-10	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,700	$0.00	$0	8,268
2019-04-10	Cogan John Francis	Dir	Open-market sell S	Common Stock	2,700	$67.23	$181,521	54,860
2019-04-10	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	2,700	$22.02	$59,440	57,560
2019-04-03	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,700	$0.00	$0	10,968
2019-04-03	Cogan John Francis	Dir	Open-market sell S	Common Stock	2,700	$66.74	$180,198	54,860
2019-04-03	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	2,700	$22.02	$59,440	57,560
2019-04-01	Whitley Richard James	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	9,534	$0.00	$0	9,534
2019-04-01	Whitley Richard James	Dir	Open-market sell S	Common Stock	9,534	$65.48	$624,255	25,135
2019-04-01	Whitley Richard James	Dir	Exercise / conversion M	Common Stock	9,534	$22.02	$209,891	34,669
2019-03-28	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	233	$0.00	$0	23,776
2019-03-27	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,700	$0.00	$0	13,668
2019-03-27	Cogan John Francis	Dir	Open-market sell S	Common Stock	2,700	$64.14	$173,178	54,860
2019-03-27	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	2,700	$22.02	$59,440	57,560
2019-03-20	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	2,700	$0.00	$0	16,368
2019-03-20	Cogan John Francis	Dir	Open-market sell S	Common Stock	2,700	$65.07	$175,689	54,860
2019-03-20	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	2,700	$22.02	$59,440	57,560
2019-03-01	O'Day Daniel Patrick	Chairman & CEO	Equity grant / award A · derivative	Restricted Stock Unit	128,770	$0.00	$0	174,220
2019-03-01	O'Day Daniel Patrick	Chairman & CEO	Equity grant / award A · derivative	Restricted Stock Unit	45,450	$0.00	$0	45,450
2019-03-01	O'Day Daniel Patrick	Chairman & CEO	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	231,280	$0.00	$0	231,280
2019-02-25	Washington Robin L	EVP, CFO	Other acquired transaction J	Common Stock	330	$0.00	$0	117,323
2019-02-19	WILSON GAYLE E	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	19,068	$0.00	$0	0
2019-02-19	WILSON GAYLE E	Dir	Open-market sell S	Common Stock	19,068	$67.08	$1,279,074	124,499
2019-02-19	WILSON GAYLE E	Dir	Exercise / conversion M	Common Stock	19,068	$0.00	$0	143,567
2019-02-15	Washington Robin L	EVP, CFO	Equity grant / award A	Common Stock	330	$57.45	$18,959	21,950
2019-02-15	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Equity grant / award A	Common Stock	330	$57.45	$18,959	33,014
2019-02-12	Washington Robin L	EVP, CFO	Other acquired transaction J	Common Stock	11,588	$0.00	$0	116,993
2019-02-06	McHutchison John G	Chief Scientific Off/HeadR&D	Equity grant / award A · derivative	Restricted Stock Unit	14,550	$0.00	$0	16,015
2019-02-06	McHutchison John G	Chief Scientific Off/HeadR&D	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	67,310	$0.00	$0	67,310
2019-02-06	McHutchison John G	Chief Scientific Off/HeadR&D	Other disposed transaction F	Common Stock	4,453	$68.75	$306,144	37,828
2019-02-06	McHutchison John G	Chief Scientific Off/HeadR&D	Equity grant / award A	Common Stock	7,104	$0.00	$0	42,281
2019-02-06	McHutchison John G	Chief Scientific Off/HeadR&D	Equity grant / award A	Common Stock	8,323	$0.00	$0	35,177
2019-01-31	BARTON JACQUELINE K	Dir	Exercise / conversion M · derivative	Restricted Stock Unit	480	—	—	2,283
2019-01-31	BARTON JACQUELINE K	Dir	Exercise / conversion M	Common Stock	480	—	—	13,740
2018-12-28	Whitley Richard James	Dir	Equity grant / award A · derivative	Phantom Stock	61	$0.00	$0	6,705
2018-12-17	McHutchison John G	Chief Scientific Off/HeadR&D	Other disposed transaction F	Common Stock	2,988	$65.12	$194,579	26,854
2018-12-17	McHutchison John G	Chief Scientific Off/HeadR&D	Equity grant / award A	Common Stock	6,135	$0.00	$0	29,842
2018-12-03	MARTIN JOHN C	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	50,000	$0.00	$0	0
2018-12-03	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	200	$72.67	$14,533	2,877,762
2018-12-03	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	13,958	$71.95	$1,004,275	2,877,962
2018-12-03	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	35,842	$70.90	$2,541,370	2,891,920
2018-12-03	MARTIN JOHN C	Dir	Exercise / conversion M	Common Stock	50,000	$23.60	$1,180,000	2,927,762
2018-11-29	MARTIN JOHN C	Dir	Equity grant / award G	Common Stock	140,000	$0.00	$0	2,877,762
2018-11-27	MILLIGAN JOHN F	President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	280,000	$0.00	$0	0
2018-11-27	MILLIGAN JOHN F	President and CEO	Exercise / conversion M	Common Stock	280,000	$23.60	$6,608,000	1,574,306
2018-11-10	McHutchison John G	Chief Scientific Off/HeadR&D	Exercise / conversion M · derivative	Restricted Stock Unit	1,465	—	—	1,465
2018-11-10	McHutchison John G	Chief Scientific Off/HeadR&D	Other disposed transaction F	Common Stock	664	$71.18	$47,264	23,707
2018-11-10	McHutchison John G	Chief Scientific Off/HeadR&D	Exercise / conversion M	Common Stock	1,465	—	—	24,371
2018-11-01	MARTIN JOHN C	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	50,000	$0.00	$0	50,000
2018-11-01	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	13,579	$70.15	$952,632	3,017,762
2018-11-01	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	28,421	$69.53	$1,976,135	3,031,341
2018-11-01	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	8,000	$68.61	$548,850	3,059,762
2018-11-01	MARTIN JOHN C	Dir	Exercise / conversion M	Common Stock	50,000	$23.60	$1,180,000	3,067,762
2018-10-07	Hamill Laura	EVP, Worldwide Commercial Ops	Equity grant / award A · derivative	Restricted Stock Unit	32,795	—	—	32,795
2018-10-07	Hamill Laura	EVP, Worldwide Commercial Ops	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	87,680	$0.00	$0	87,680
2018-10-01	MARTIN JOHN C	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	50,000	$0.00	$0	100,000
2018-10-01	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	16,670	$78.34	$1,305,853	3,017,762
2018-10-01	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	33,330	$77.90	$2,596,357	3,034,432
2018-10-01	MARTIN JOHN C	Dir	Exercise / conversion M	Common Stock	50,000	$23.60	$1,180,000	3,067,762
2018-09-27	Whitley Richard James	Dir	Equity grant / award A · derivative	Phantom Stock	49	$0.00	$0	6,644
2018-09-04	MARTIN JOHN C	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	50,000	$0.00	$0	150,000
2018-09-04	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	2,624	$75.00	$196,790	3,017,762
2018-09-04	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	47,376	$74.11	$3,511,244	3,020,386
2018-09-04	MARTIN JOHN C	Dir	Exercise / conversion M	Common Stock	50,000	$23.60	$1,180,000	3,067,762
2018-08-15	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Equity grant / award A	Common Stock	94	$63.61	$5,980	20,706
2018-08-10	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Exercise / conversion M · derivative	Restricted Stock Unit	1,070	—	—	1,070
2018-08-10	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Other disposed transaction F	Common Stock	489	$76.73	$37,521	20,612
2018-08-10	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Exercise / conversion M	Common Stock	1,070	—	—	21,101
2018-08-01	MARTIN JOHN C	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	50,000	$0.00	$0	200,000
2018-08-01	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	50,000	$77.85	$3,892,650	3,017,762
2018-08-01	MARTIN JOHN C	Dir	Exercise / conversion M	Common Stock	50,000	$23.60	$1,180,000	3,067,762
2018-07-31	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Exercise / conversion M · derivative	Restricted Stock Unit	2,000	—	—	2,140
2018-07-31	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Other disposed transaction F	Common Stock	910	$77.83	$70,825	20,031
2018-07-31	Pletcher Brett A	EVP, Gen Counsel & Corp Sec	Exercise / conversion M	Common Stock	2,000	—	—	20,941
2018-07-02	MARTIN JOHN C	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	50,000	$0.00	$0	250,000
2018-07-02	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	300	$71.36	$21,408	3,017,762
2018-07-02	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	49,700	$70.80	$3,518,874	3,018,062
2018-07-02	MARTIN JOHN C	Dir	Exercise / conversion M	Common Stock	50,000	$23.60	$1,180,000	3,067,762
2018-07-01	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	1,623	$0.00	$0	23,156
2018-06-28	Whitley Richard James	Dir	Equity grant / award A · derivative	Phantom Stock	53	$0.00	$0	6,595
2018-06-01	MARTIN JOHN C	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	50,000	$0.00	$0	300,000
2018-06-01	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	50,000	$68.13	$3,406,495	3,017,762
2018-06-01	MARTIN JOHN C	Dir	Exercise / conversion M	Common Stock	50,000	$23.60	$1,180,000	3,067,762
2018-05-09	MARTIN JOHN C	Dir	Equity grant / award A · derivative	Restricted Stock Unit	2,283	—	—	2,593
2018-05-09	MARTIN JOHN C	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	9,496	$0.00	$0	9,496
2018-05-08	McHutchison John G	Chief Scientific Off/HeadR&D	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	79,710	$65.22	$5,198,686	79,710
2018-05-04	MILLIGAN JOHN F	President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	80,000	$0.00	$0	0
2018-05-04	MILLIGAN JOHN F	President and CEO	Exercise / conversion M	Common Stock	80,000	$27.07	$2,165,600	1,294,306
2018-05-01	MARTIN JOHN C	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	50,000	$0.00	$0	350,000
2018-05-01	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	50,000	$72.19	$3,609,660	3,017,762
2018-05-01	MARTIN JOHN C	Dir	Exercise / conversion M	Common Stock	50,000	$23.60	$1,180,000	3,067,762
2018-04-27	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,833	$0.00	$0	5,836
2018-04-27	Cogan John Francis	Dir	Open-market sell S	Common Stock	5,833	$73.91	$431,117	52,619
2018-04-27	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	5,833	$26.61	$155,245	58,452
2018-04-20	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,833	$0.00	$0	11,669
2018-04-20	Cogan John Francis	Dir	Open-market sell S	Common Stock	5,333	$73.77	$393,435	52,619
2018-04-20	Cogan John Francis	Dir	Open-market sell S	Common Stock	500	$73.39	$36,696	57,952
2018-04-20	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	5,833	$26.61	$155,245	58,452
2018-04-13	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,833	$0.00	$0	17,502
2018-04-13	Cogan John Francis	Dir	Open-market sell S	Common Stock	5,833	$75.56	$440,741	52,619
2018-04-13	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	5,833	$26.61	$155,245	58,452
2018-04-06	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,833	$0.00	$0	23,335
2018-04-06	Cogan John Francis	Dir	Open-market sell S	Common Stock	5,833	$74.47	$434,384	52,619
2018-04-06	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	5,833	$26.61	$155,245	58,452
2018-04-02	MARTIN JOHN C	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	50,000	$0.00	$0	400,000
2018-04-02	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	700	$74.98	$52,484	3,017,762
2018-04-02	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	9,962	$74.33	$740,466	3,018,462
2018-04-02	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	13,080	$73.39	$959,890	3,028,424
2018-04-02	MARTIN JOHN C	Dir	Open-market sell S	Common Stock	26,258	$72.51	$1,903,965	3,041,504
2018-04-02	MARTIN JOHN C	Dir	Exercise / conversion M	Common Stock	50,000	$23.60	$1,180,000	3,067,762
2018-03-29	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	160	$0.00	$0	21,359
2018-03-23	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,833	$0.00	$0	35,001
2018-03-23	Cogan John Francis	Dir	Open-market sell S	Common Stock	5,833	$75.02	$437,588	52,619
2018-03-23	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	5,833	$26.61	$155,245	58,452
2018-03-16	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,833	$0.00	$0	40,834
2018-03-16	Cogan John Francis	Dir	Open-market sell S	Common Stock	5,833	$80.09	$467,138	52,619
2018-03-16	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	5,833	$26.61	$155,245	58,452
2018-03-12	Cogan John Francis	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	5,833	$0.00	$0	46,667
2018-03-12	Cogan John Francis	Dir	Open-market sell S	Common Stock	5,833	$80.93	$472,065	52,619
2018-03-12	Cogan John Francis	Dir	Exercise / conversion M	Common Stock	5,833	$26.61	$155,245	58,452
2018-03-09	MARTIN JOHN C	Dir	Equity grant / award A · derivative	Restricted Stock Unit	310	—	—	310
2018-03-09	MARTIN JOHN C	Dir	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	1,309	$0.00	$0	1,309
2018-03-01	MOORE NICHOLAS G	Dir	Exercise / conversion M · derivative	Phantom Stock	178	$0.00	$0	27,170
2018-03-01	MOORE NICHOLAS G	Dir	Exercise / conversion M	Common Stock	178	$0.00	$0	12,233
2018-02-28	Washington Robin L	EVP, CFO	Open-market sell S	Common Stock	5,000	$80.31	$401,566	105,405
2018-02-28	Washington Robin L	EVP, CFO	Equity grant / award G	Common Stock	6,588	$0.00	$0	110,405
2018-02-21	Alton Gregg H	EVP,Corporate &Medical Affairs	Other disposed transaction F	Common Stock	5,894	$80.69	$475,587	52,176
2018-02-21	Alton Gregg H	EVP,Corporate &Medical Affairs	Equity grant / award A	Common Stock	5,672	$0.00	$0	58,070
2018-02-21	Alton Gregg H	EVP,Corporate &Medical Affairs	Equity grant / award A	Common Stock	14,320	$0.00	$0	52,398
2018-02-21	Washington Robin L	EVP, CFO	Equity grant / award G	Common Stock	340	$0.00	$0	103,817
2018-02-20	Alton Gregg H	EVP,Corporate &Medical Affairs	Open-market sell S	Common Stock	14,435	$81.54	$1,176,992	0
2018-02-15	Alton Gregg H	EVP,Corporate &Medical Affairs	Equity grant / award A	Common Stock	340	$62.35	$21,198	38,078
2018-02-10	YOUNG KEVIN	Chief Operating Officer	Exercise / conversion M · derivative	Restricted Stock Unit	908	$0.00	$0	3,184
2018-02-10	YOUNG KEVIN	Chief Operating Officer	Other disposed transaction F	Common Stock	425	$79.32	$33,711	15,812
2018-02-10	YOUNG KEVIN	Chief Operating Officer	Exercise / conversion M	Common Stock	908	$0.00	$0	16,237
2018-02-09	WILSON GAYLE E	Dir	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	60,000	$0.00	$0	0
2018-02-09	WILSON GAYLE E	Dir	Open-market sell S	Common Stock	60,000	$77.92	$4,675,080	122,258
2018-02-09	WILSON GAYLE E	Dir	Exercise / conversion M	Common Stock	60,000	$26.61	$1,596,900	182,258
2018-02-01	YOUNG KEVIN	Chief Operating Officer	Exercise / conversion M · derivative	Restricted Stock Unit	620	$0.00	$0	4,092
2018-02-01	YOUNG KEVIN	Chief Operating Officer	Other disposed transaction F	Common Stock	218	$83.49	$18,201	15,329
2018-02-01	YOUNG KEVIN	Chief Operating Officer	Exercise / conversion M	Common Stock	620	$0.00	$0	15,547
2018-02-01	Alton Gregg H	EVP,Corporate &Medical Affairs	Equity grant / award A · derivative	Non-qualified Stock Option (Right to Buy)	62,910	$0.00	$0	62,910
2018-02-01	Alton Gregg H	EVP,Corporate &Medical Affairs	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	17,250	$0.00	$0	72,846
2018-02-01	Alton Gregg H	EVP,Corporate &Medical Affairs	Open-market sell S	Common Stock	15,214	$83.66	$1,272,805	37,738
2018-02-01	Alton Gregg H	EVP,Corporate &Medical Affairs	Open-market sell S	Common Stock	9,786	$83.29	$815,055	52,952
2018-02-01	Alton Gregg H	EVP,Corporate &Medical Affairs	Exercise / conversion M	Common Stock	17,250	$40.56	$699,660	62,738
2018-01-31	YOUNG KEVIN	Chief Operating Officer	Other disposed transaction F	Common Stock	2,259	$83.80	$189,304	14,927
2018-01-31	YOUNG KEVIN	Chief Operating Officer	Equity grant / award A	Common Stock	7,110	$0.00	$0	17,186
2018-01-16	Meyers James R	EVP Worldwide Commercial Ops	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	100,000	$0.00	$0	0
2018-01-16	Meyers James R	EVP Worldwide Commercial Ops	Open-market sell S	Common Stock	24,843	$80.99	$2,012,097	2,715
2018-01-16	Meyers James R	EVP Worldwide Commercial Ops	Open-market sell S	Common Stock	75,157	$80.00	$6,012,267	27,558
2018-01-16	Meyers James R	EVP Worldwide Commercial Ops	Exercise / conversion M	Common Stock	100,000	$21.57	$2,157,500	102,715
2018-01-11	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	18,374	$0.00	$0	90,096
2018-01-11	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	7,501	$0.00	$0	0
2018-01-11	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Open-market sell S	Common Stock	4,125	$79.00	$325,875	45,488
2018-01-11	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Open-market sell S	Common Stock	18,374	$79.00	$1,451,546	49,613
2018-01-11	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Open-market sell S	Common Stock	7,501	$79.00	$592,579	67,987
2018-01-11	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Exercise / conversion M	Common Stock	18,374	$40.56	$745,249	75,488
2018-01-11	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Exercise / conversion M	Common Stock	7,501	$24.91	$186,812	57,114
2018-01-02	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	8,625	$0.00	$0	7,501
2018-01-02	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Open-market sell S	Common Stock	5,675	$73.86	$419,133	49,613
2018-01-02	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Open-market sell S	Common Stock	700	$72.34	$50,636	55,288
2018-01-02	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Open-market sell S	Common Stock	8,625	$74.00	$638,250	55,988
2018-01-02	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Exercise / conversion M	Common Stock	8,625	$24.91	$214,806	64,613
2017-12-28	Whitley Richard James	Dir	Equity grant / award A · derivative	Phantom Stock	46	$0.00	$0	6,493
2017-12-01	MARTIN JOHN C	Executive Chairman	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	73,333	$0.00	$0	0
2017-12-01	MARTIN JOHN C	Executive Chairman	Open-market sell S	Common Stock	12,500	$74.35	$929,409	2,996,766
2017-12-01	MARTIN JOHN C	Executive Chairman	Open-market sell S	Common Stock	101	$75.57	$7,633	3,009,266
2017-12-01	MARTIN JOHN C	Executive Chairman	Open-market sell S	Common Stock	60,732	$75.11	$4,561,344	3,009,367
2017-12-01	MARTIN JOHN C	Executive Chairman	Exercise / conversion M	Common Stock	73,333	$21.57	$1,582,159	3,070,099
2017-11-20	BISCHOFBERGER NORBERT W	EVP, R&D and CSO	Equity grant / award G	Common Stock	10,000	$0.00	$0	2,308,407
2017-11-13	MILLIGAN JOHN F	President and CEO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	220,000	$0.00	$0	0
2017-11-13	MILLIGAN JOHN F	President and CEO	Open-market sell S	Common Stock	220,000	$72.88	$16,034,678	1,165,924
2017-11-13	MILLIGAN JOHN F	President and CEO	Exercise / conversion M	Common Stock	220,000	$21.57	$4,746,500	1,385,924
2017-11-09	YOUNG KEVIN	Chief Operating Officer	Other disposed transaction F	Common Stock	3,422	$73.02	$249,874	10,076
2017-11-09	YOUNG KEVIN	Chief Operating Officer	Equity grant / award A	Common Stock	6,810	$0.00	$0	13,498
2017-11-05	Meyers James R	EVP Worldwide Commercial Ops	Exercise / conversion M · derivative	Restricted Stock Unit	4,500	$0.00	$0	4,460
2017-11-05	Meyers James R	EVP Worldwide Commercial Ops	Equity grant / award G	Common Stock	2,288	$0.00	$0	128,433
2017-11-05	Meyers James R	EVP Worldwide Commercial Ops	Other disposed transaction F	Common Stock	2,212	$73.46	$162,494	5,003
2017-11-05	Meyers James R	EVP Worldwide Commercial Ops	Exercise / conversion M	Common Stock	4,500	$0.00	$0	7,215
2017-11-01	MARTIN JOHN C	Executive Chairman	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	73,333	$0.00	$0	73,333
2017-11-01	MARTIN JOHN C	Executive Chairman	Open-market sell S	Common Stock	7,477	$75.60	$565,295	2,996,766
2017-11-01	MARTIN JOHN C	Executive Chairman	Open-market sell S	Common Stock	65,856	$75.08	$4,944,403	3,004,243
2017-11-01	MARTIN JOHN C	Executive Chairman	Exercise / conversion M	Common Stock	73,333	$21.57	$1,582,159	3,070,099
2017-10-02	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	17,250	$0.00	$0	33,376
2017-10-02	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Open-market sell S	Common Stock	2,141	$83.52	$178,819	68,738
2017-10-02	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Open-market sell S	Common Stock	19,938	$82.68	$1,648,432	70,879
2017-10-02	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Open-market sell S	Common Stock	2,921	$81.84	$239,056	90,817
2017-10-02	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Exercise / conversion M	Common Stock	17,250	$24.91	$429,611	93,738
2017-09-28	Lofton Kevin E	Dir	Equity grant / award A · derivative	Phantom Stock	134	$0.00	$0	21,048
2017-09-07	Washington Robin L	EVP, CFO	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	33,750	$0.00	$0	0
2017-09-07	Washington Robin L	EVP, CFO	Open-market sell S	Common Stock	18,070	$85.00	$1,535,950	103,477
2017-09-07	Washington Robin L	EVP, CFO	Open-market sell S	Common Stock	33,750	$85.00	$2,868,750	9,602
2017-09-07	Washington Robin L	EVP, CFO	Exercise / conversion M	Common Stock	33,750	$24.30	$819,956	43,352
2017-09-01	MARTIN JOHN C	Executive Chairman	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	73,333	$0.00	$0	219,999
2017-09-01	MARTIN JOHN C	Executive Chairman	Open-market sell S	Common Stock	14,995	$83.43	$1,251,094	2,996,766
2017-09-01	MARTIN JOHN C	Executive Chairman	Open-market sell S	Common Stock	58,338	$83.03	$4,843,897	3,011,761
2017-09-01	MARTIN JOHN C	Executive Chairman	Exercise / conversion M	Common Stock	73,333	$21.57	$1,582,159	3,070,099
2017-09-01	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Exercise / conversion M · derivative	Non-qualified Stock Option (Right to Buy)	17,250	$0.00	$0	50,626
2017-09-01	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Open-market sell S	Common Stock	3,737	$83.54	$312,207	76,488
2017-09-01	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Open-market sell S	Common Stock	21,263	$82.96	$1,763,981	80,225
2017-09-01	Alton Gregg H	EVP Comm&Acs ALA, Corp&Med Aff	Exercise / conversion M	Common Stock	17,250	$24.91	$429,611	101,488
2017-08-31	MARTIN JOHN C	Executive Chairman	Equity grant / award G	Common Stock	129,870	$0.00	$0	2,996,766

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count